Toggle light / dark theme

Elon Musk has made the argument that Tesla is more of an AI (artificial intelligence) and robotics company. This is another argument in the series of Musk’s insistence that Tesla is not an automotive company. He has been saying for some time now that investors should view Tesla as a group of startups. He says that Tesla’s service centres are a startup, Tesla’s insurance company is a startup, Tesla’s automation group is a startup, etc.

Musk said that eventually, Tesla is going to be as synonymous with AI and robotics as with vehicles and energy. The CEO mentioned this during a conference call about Tesla’s Q1 financial results.

Right now people think of Tesla as a car company or as an energy company. I think long term, people will think of Tesla as much as an AI robotics company as we are a car company or an energy company. I think we are developing one of the strongest hardware and software AI teams in the world.

Thank you to China for trying to surpass the USA in Ai, otherwise they’d never open the wallet to fund this AI research. AGI 2025!!


China is showcasing its advances in the field of artificial intelligence — at an annual tech-themed forum.
It is being held in the port city of Tianjin.
Super computers, rockets and robots are among the innovations on display.
The event comes just months after the United States National Security Commission said that China is on track to overtake the US as the world’s AI superpower.
Al Jazeera’s Katrina Yu reports.

- Subscribe to our channel: http://aje.io/AJSubscribe.
- Follow us on Twitter: https://twitter.com/AJEnglish.
- Find us on Facebook: https://www.facebook.com/aljazeera.
- Check our website: https://www.aljazeera.com/

#China

Aging, DNA Repair, And Clinical Innovation — Dr. Morten Scheibye-Knudsen — University of Copenhagen.


Dr. Morten Scheibye-Knudsen is an Associate Professor at the Department of Cellular and Molecular Medicine, and at the Center for Healthy Aging (CEHA), at the University of Copenhagen.

Dr. Scheibye-Knudsen did his MD at the University of Copenhagen and worked briefly as a physician in Denmark and Greenland before turning to science. He did his post-doctoral fellowship at Vilhelm Bohr’s lab at the National Institute on Aging, National Institutes of Health, USA, where he utilized state-of-the art approaches to understand how DNA damage contributes to aging, discovering that neurodegeneration in several premature aging diseases is partly caused by hyperactivation of a DNA damage responsive enzyme called polyADP-ribose polymerase 1 (PARP1). This activation leads to loss of vital metabolites such as Nicotinamide Adenine Dinucleotide (NAD+) and acetyl-CoA. Importantly, this discovery facilitated the realization that we can intervene in the aging process by inhibiting PARP1, augmenting NAD+ levels and increasing acetyl-CoA.

In his own lab Dr. Scheibye-Knudsen continues to focus on understanding aging by combining machine learning based approaches with wet-lab analyses with the goal of developing interventions for age-associated diseases and perhaps aging itself.

Dr. Scheibye-Knudsen is Chief Editor, Frontiers in Aging, and an Advisory Board Member of the Longevity Vision Fund and Molecule Protocol.

Pediatrician, Medical Innovator, Educator — Dr. Jamie Wells, MD, FAAP — Director, Research Science Institute (RSI), Center for Excellence in Education, Massachusetts Institute of Technology (MIT) — Professor, Drexel University School of Biomedical Engineering, Science and Health Systems.


Dr. Jamie L. Wells, MD, FAAP, is an Adjunct Professor at Drexel University’s School of Biomedical Engineering, Science and Health Systems, where she has been involved in helping to spearhead the nation’s first-degree program focused on pediatric engineering, innovation, and medical advancement.

Dr. Wells is an award-winning Board-certified pediatrician with many years of experience caring for patients. With her BA with Honors from Yale, and her MD from Jefferson Medical College, Philadelphia, PA, she has served as a Clinical Instructor/Attending at NYU Langone, Mt. Sinai-Beth Israel and St. Vincent’s Medical Centers in Manhattan.

Dr. Wells also serves as Director of the Research Science Institute (RSI), at Center for Excellence in Education (CEE), a non-profit, 501©(3) organization, collaboratively sponsored with MIT bring together top U.S. and international high school students for an intensive, six-week summer program that provides students with the opportunity to conduct original, cutting-edge research.

Dr. Wells is on the leadership council of the Wistar Institute (the USA’s first independent biomedical research facility and certified cancer center), Ambassador of the Healthcare Global Blockchain Business Council, was a grant reviewer for the Susan G. Komen Community Grants Program, judged both the local, district and world robotics championships for Dean Kamen’s F.I.R.S.T. (For Inspiration & Recognition of Science & Technology) nonprofit, as well as the Miss America’s Outstanding Teen scholarship competition (for which she is now a member of its Board of Directors), and is the Chair of the Yale Alumni Health Network (YAHN).

“Clearly AI is going to win[against human intelligence]. It’s not even close,” Kahneman told the paper. “How people are going to adjust to this is a fascinating problem.”

Of course, and the reaction, right up to the last minute will be: “No way Man!!! there will be new jobs these crazy Ai’s cant do!”


Artificial intelligence will be beating humans — outworking if not entirely outmoding them — in plenty of functions as the future approaches. Here’s why.

There goes the Coder Camps.


IBM has announced Project CodeNet, a large dataset that aims to help teach AI how to understand and even write code.

Project CodeNet was announced at IBM’s Think conference this week and claims to be the largest open-source dataset for code (approximately 10 times the size of the closest.)

CodeNet features 500 million lines of code, 14 million examples, and spans 55 programming languages including Python, C++, Java, Go, COBOL, Pascal, and more.

Splunk today announced it plans to acquire security software company TruStar for an undisclosed amount. The acquisition will add TruStar’s cloud-native, cyber intelligence-sharing capabilities and automated processes to Splunk’s growing cybersecurity portfolio.

“TruStar will help us get even better at predictive threat assessments by strengthening our threat intelligence framework. This acquisition will allow customers to autonomously and seamlessly enrich their (security operation center) workflows with threat intelligence data feeds from heterogeneous sources,” Splunk president and CEO Doug Merritt told VentureBeat in an exclusive interview.

The pending deal is in line with Splunk’s philosophy that “security is a data problem,” he said. The announcement marks a return to M&A activity for Splunk and the massive $1.05 billion deal for SignalFX in 2019. The company also made four cloud-related acquisitions in 2020.